Angiogenesis in pathological and surgical scars

Human Pathology

Volumn 29, Issue 11, 1998, Pages 1273-1278

  Beer, Trevor W ^a   Baldwin, Heather ^b   Goddard, Jonathon R ^b   Gallagher, Patrick J ^b   Wright, Dennis H ^b  

^a ROYAL HOSPITAL HASLAR   (United Kingdom)

^b NONE

Author keywords

Angiogenesis; Cicatrix; Hypertrophic scar; Keloid

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HEALING; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; KELOID; MALE; MAST CELL; SCAR; STATISTICAL ANALYSIS; VASCULARIZATION;

EID: 0031787529     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90256-8     Document Type: Article

References (37)

1. Chrisman BB: Blepharoplasty and browlift with surgical variations in non-white patients. J Dermatol Surg Oncol 12:58-66, 1986
2. Offret H, Quillard J: Nodule cheloidien du bord libre de la paupiere. J Fr Ophthalmol 16:552-553, 1993
3. Rockwell WB, Cohen IK, Ehrlich HP: Keloids and hypertrophic scars: A comprehensive review. Plast Reconstr Surg 84:827-837, 1989
4. McGrouther DA: Hypertrophic or keloid scars? Eye 8:200-203, 1994
5. Kischer CW, Thies AC, Chvapil M: Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. HUM PATHOL 13:819-824, 1982
6. Thomas DW, Hopkinson I, Harding KG, et al: The pathogenesis of hypertrophic/keloid scarring. Int J Oral Maxillofac Surg 23:232-236, 1994
7. Kischer CW: The microvessels in hypertrophic scars, keloids and related lesions: A review. J Submicrosc Cytol Pathol 24:281-296, 1992
8. Ehrlich HP, Desmouliere A, Diegelmann RF, et al: Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105-113, 1994
9. McKee PH (ed): Pathology of the Skin with Clinical Correlations (ed 2). London, England, Mosby-Wolfe, 1996, pp 16.8-16.9
10. Beer TW, Baldwin H, West L, et al: Mast cells at pathological and surgical scar sites. Br J Ophthalmol 82:691-694, 1998
11. Smith CJ, Smith JC, Finn MC: The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. J Burn Care Rehabil 8:126-131, 1987
12. Meininger CJ, Zetter BR: Mast Cells and Angiogenesis. Semin Cancer Biol 3:73-79, 1992
13. Lametschwandtner A, Staindl O: The vascular architecture of the keloid: A scanning electron microscope study on vascular corrosion casts. HNO 38:202-207, 1990
14. Takemura G, Takatsu Y, Fujiwara H: Luminal narrowing of capillaries in human hypertrophic hearts: An ultrastructural morphometrical study using endomyocardial biopsy specimens. Heart 79:78-85, 1998
15. Zuber TJ, DeWitt DE: Earlobe keloids. Am Fam Physician 49:1835-1841, 1994
16. Murray JC: Scars and keloids. Dermatol Clin 11:697-708, 1993
17. Norris JE: Superficial x-ray therapy in keloid management: A retrospective study of 24 cases and literature review. Plast Reconstr Surg 95:1051-1055, 1995
18. Suzawa H, Kikuchi S, Arai N, et al: The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 60:91-96, 1992
19. Riaz Y, Cook HT, Wangoo A, et al: Type 1 procollagen as a marker of severity of scarring after sternotomy: Effects of topical corticosteroids. J Clin Pathol 47:892-899, 1994
20. Zhang K, Garner W, Cohen L, et al: Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol 104:750-754, 1995
21. Border WA, Nobe NA: Transforming growth factor aβ in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
22. Shah M, Foreman DM, Ferguson MWJ: Neutralisation of TGF-beta 1 and TGF-beta2 or exogenous addition of TGF-beta3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985-1002, 1995
23. Ferguson MWJ: Skin wound healing: Transforming growth factor beta antagonists decrease scarring and improve quality. J Interferon Res 14:303-304, 1994
24. Nath RK, LaRegina M, Markham H, et al: The expression of transforming growth factor type beta in fetal and adult rabbit skin wounds. J Pediatr Surgy 29:416-421, 1994
25. 3 during excisional wound repair. Am J Pathol 143:368-380, 1993
26. Altman DA, Nickoloff BJ, Fivenson DP: Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumours. J Cutan Pathol 20:154-158, 1993
27. Cerio R, Spaull J, Jones EW: Histiocytoma cutis: A tumour of dermal dendrocytes (dermal dendrocytoma). Br J Dermatol 120:197-206, 1989
28. Pierard GE, Arrese-Estrada J, Pierard-Franchimont C, et al: Is there a link between dendrocytes, fibrosis and sclerosis? Dermatologica 181:264-265, 1990
29. Pierard-Franchimont C, Arrese JE, Nikkels AF, et al: Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers. Virchows Arch A Pathol Anat Histopathol 429:43-48, 1996
30. Hoyo E, Kanitakis J, Schmitt D: The dermal dendrocyte. Pathol Biol 41:613-618, 1993
31. Suvarna SK, Cotton DWK: Dermal dendrocytes and other factor XIIIA-positive cells. J Pathol 171:251-252, 1993
32. Penneys NS: Factor XIII expression in the skin: Observations and a hypothesis. J Am Acad Dermatol 22:484-488, 1990
33. Schaumburg-Lever G, Gehring B, Kaiserling E: Ultrastructural localisation of factor XIIIa. J Cutan Pathol 21:129-134, 1994
34. Trabucchi E, Radaelli E, Marazzi M, et al: The role of mast cells in wound healing. Int J Tissue Reac X:367-372, 1988
35. Arbiser JL: Angiogenesis and the skin: A primer. J Am Acad Dermatol 34:486-497, 1996
36. Brody GS: Keloids and hypertrophic scars. Plast Reconstr Surg 86:804, 1990
37. NorrisJE: Hypertrophic scar and keloid [letter]. Plast Reconstr Surg 88:372-373, 1991